Yun et al. previously proved that a high c-MYC expression is an independent poor prognostic factor for the overall survival outcome in AML, however, the influence on survival was confirmed only in cases of no TP53 somatic mutations or del(17p) [32]. This evidence concerns the gene TP53 and acute myeloid leukemia.